课题基金 / 基金详情

项目摘要

项目成果

Vance G. Fowler的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):本赠款申请的目的是申请资金以部分支持2011年戈登葡萄球菌研究会议,该会议将于2011年7月24-29日在意大利卢卡(巴加)的Il Ciocco酒店及度假村举行。本次会议旨在提高葡萄球菌研究领域的科学知识,将该领域最有才华和最多产的研究人员聚集在一起,提供一个促进科学对话的环境,并通过在日程安排中提供足够的自由时间以允许临时会议来促进新的合作。戈登研究会议的设计具有很高的创新性。对葡萄球菌有共同专业兴趣的科学家齐聚一堂,对其领域最先进的方面进行了整整一周的激烈讨论和审查。并挑战了当前大型科学会议的范式。会议的所有议事程序均禁止公众使用。2011年第12届戈登葡萄球菌会议将介绍有关重要病原体金黄色葡萄球菌和凝固酶阴性葡萄球菌的前沿研究。这次会议的主题包括:宿主相互作用、免疫逃避、进化、生理学、细胞表面、治疗学和患者管理。来自学术界和工业界的受邀演讲者将站在各自主题的前沿,介绍他们最新的未发表研究。所有与会者将有机会展示海报,并与葡萄球菌领域的领导人交流想法。与往年一样,来自年轻研究人员的最佳海报将被选为简短的口头演示。这次会议气氛热烈,有组织的讨论会议以及在下午和晚上举行非正式聚会的机会,为来自不同学科的科学家交流思想、集思广益和促进跨学科合作提供了理想的环境。 公共卫生相关性:葡萄球菌是人类的主要病原体。耐甲氧西林金黄色葡萄球菌现在是美国其他健康社区居民软组织感染的最常见可识别的原因。对万古霉素、利奈唑胺和达托霉素耐药的金黄色葡萄球菌分离株的鉴定表明,病原体可能对所有可用的治疗方法都具有耐药性。葡萄球菌的抗菌素耐药性、流行病学、发病机制、治疗和预防方面的发展正从日益国际化的研究人员中迅速发展起来。因此,必须为葡萄球菌研究界提供一个促进讨论和思想自由交流的论坛。通过追求这些具体目标,2011年的葡萄球菌疾病全球研究委员会将通过聚集该领域最有才华和最有成效的研究人员,提供一个促进科学对话的环境,并通过在时间表中提供足够的自由时间来允许临时会议,来促进新的合作,从而提高对葡萄球菌发病机制的科学知识。
英文摘要
DESCRIPTION (provided by applicant): The purpose of this Grant submission is to request funds to partially support the 2011 Gordon Research Conference in Staphylococci, which will be held July 24-29, 2011 at the Il Ciocco Hotel and Resort, in Lucca (Barga), Italy. This conference seeks to improve scientific knowledge in the field of staphylococcal research by bringing together the most talented and productive researchers in the field, providing an environment that fosters scientific dialogue, and catalyzing new collaborations by providing sufficient free time in the schedule to allow for impromptu meetings. The Gordon Research Conference design is highly innovative. Scientists with common professional interests in the staphylococci come together for a full week of intense discussion and examination of the most advanced aspects of their field.and challenges current paradigm of the large scientific conference. All proceedings of the meetings are restricted for public use. The 12th Gordon Conference on Staphylococcal Diseases 2011 will present cutting-edge research on the important pathogens S. aureus and coagulase-negative staphylococci. Topics at this meeting will include: host interaction, immune evasion, evolution, physiology, cell surfaces, therapeutics and patient management. Invited speakers from academia and industry who are at the forefront of their subject will be presenting their latest unpublished research. All attendees will have the opportunity to present posters and exchange ideas with leaders in the staphylococcal field. As in previous years, the best posters from younger researchers will be selected for short oral presentations. The collegial atmosphere of this Conference, with organized discussion sessions as well as opportunities for informal gatherings in the afternoons and evenings, provides an ideal setting for scientists from different disciplines to exchange ideas, brainstorm and foster cross-disciplinary collaborations. PUBLIC HEALTH RELEVANCE: Staphylococci are leading human pathogens. Methicillin resistant Staphylococcus aureus is now the most common identifiable cause of soft tissue infection among otherwise healthy community residents in the United States. The identification of S. aureus isolates resistant to vancomycin, linezolid, and daptomycin, indicates the possibility of a pathogen resistant to all available therapy. Developments in antimicrobial resistance, epidemiology, pathogenesis, treatment, and prevention of staphylococci are occurring at a rapid pace from an increasingly international community of investigators. Thus, it is essential to provide the staphylococcal research community with a forum to promote discussions and the free exchange of ideas. By pursuing these Specific Aims The GRC on Staphylococcal Diseases in 2011 will improve scientific knowledge in staphylococcal pathogenesis by bringing together the most talented and productive researchers in the field, providing an environment that fosters scientific dialogue, and catalyzing new collaborations by providing sufficient free time in the schedule to allow for impromptu meetings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HLA Fine Mapping to Elucidate S. aureus Susceptibility
  • 批准号:
    10490895
  • 项目类别:
  • 资助金额:
    $78.06万
  • 财政年份:
    2021
  • 负责人:
    Vance G. Fowler
  • 依托单位:
HLA Fine Mapping to Elucidate S. aureus Susceptibility
  • 批准号:
    10344003
  • 项目类别:
  • 资助金额:
    $80.7万
  • 财政年份:
    2021
  • 负责人:
    Vance G. Fowler
  • 依托单位:
2013 Staphylococcal Diseases Gordon Research Conference and Gordon Research Semin
  • 批准号:
    8526118
  • 项目类别:
  • 资助金额:
    $0.6万
  • 财政年份:
    2013
  • 负责人:
    Vance G. Fowler
  • 依托单位:
Antibacterial Resistance Leadership Group (ARLG)
  • 批准号:
    10064119
  • 项目类别:
  • 资助金额:
    $1970.99万
  • 财政年份:
    2013
  • 负责人:
    Vance G. Fowler
  • 依托单位:
海外基金